ANAVEX LIFE SCIENCES CORP. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ANAVEX LIFE SCIENCES CORP. (AVXL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $1.20 million as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-28
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.20M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $4.70M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $4.80M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.30M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $1.20M 10-Q · filed 2026-08-28 |
| 2026-03-31 | $4.70M 10-Q · filed 2026-08-28 |
| 2025-12-31 | $4.80M 10-Q · filed 2026-02-09 |
| 2025-09-30 | $6.30M 10-K/A · filed 2026-08-28 |
| 2025-06-30 | $10.00M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $14.50M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.80M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $8.40M 10-K · filed 2024-12-23 |
| 2024-06-30 | $10.60M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $14.50M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $27.70M 10-Q · filed 2024-02-07 |
| 2023-09-30 | $14.10M 10-K · filed 2023-11-27 |
| 2023-06-30 | $17.54M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $21.78M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $16.34M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $19.03M 10-K · filed 2022-11-28 |
| 2022-06-30 | $24.28M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.03M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $18.17M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $21.65M 10-K · filed 2021-11-24 |
| 2021-06-30 | $6.66M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.09M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.19M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $4.04M 10-K · filed 2020-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |